390 related articles for article (PubMed ID: 27542226)
1. Novel regulatory role of neuropilin-1 in endothelial-to-mesenchymal transition and fibrosis in pancreatic ductal adenocarcinoma.
Matkar PN; Singh KK; Rudenko D; Kim YJ; Kuliszewski MA; Prud'homme GJ; Hedley DW; Leong-Poi H
Oncotarget; 2016 Oct; 7(43):69489-69506. PubMed ID: 27542226
[TBL] [Abstract][Full Text] [Related]
2. A novel association of neuropilin-1 and MUC1 in pancreatic ductal adenocarcinoma: role in induction of VEGF signaling and angiogenesis.
Zhou R; Curry JM; Roy LD; Grover P; Haider J; Moore LJ; Wu ST; Kamesh A; Yazdanifar M; Ahrens WA; Leung T; Mukherjee P
Oncogene; 2016 Oct; 35(43):5608-5618. PubMed ID: 26804176
[TBL] [Abstract][Full Text] [Related]
3. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
4. Neuropilin-2-mediated tumor growth and angiogenesis in pancreatic adenocarcinoma.
Dallas NA; Gray MJ; Xia L; Fan F; van Buren G; Gaur P; Samuel S; Lim SJ; Arumugam T; Ramachandran V; Wang H; Ellis LM
Clin Cancer Res; 2008 Dec; 14(24):8052-60. PubMed ID: 19088020
[TBL] [Abstract][Full Text] [Related]
5. VEGF/NRP-1axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-κB and β-catenin.
Luo M; Hou L; Li J; Shao S; Huang S; Meng D; Liu L; Feng L; Xia P; Qin T; Zhao X
Cancer Lett; 2016 Apr; 373(1):1-11. PubMed ID: 26805761
[TBL] [Abstract][Full Text] [Related]
6. Neuropilin-1 suppresses tumorigenic properties in a human pancreatic adenocarcinoma cell line lacking neuropilin-1 coreceptors.
Gray MJ; Wey JS; Belcheva A; McCarty MF; Trevino JG; Evans DB; Ellis LM; Gallick GE
Cancer Res; 2005 May; 65(9):3664-70. PubMed ID: 15867361
[TBL] [Abstract][Full Text] [Related]
7. High neuropilin 1 expression was associated with angiogenesis and poor overall survival in resected pancreatic ductal adenocarcinoma.
Ben Q; Zheng J; Fei J; An W; Li P; Li Z; Yuan Y
Pancreas; 2014 Jul; 43(5):744-9. PubMed ID: 24632553
[TBL] [Abstract][Full Text] [Related]
8. Endothelial-mesenchymal transition harnesses HSP90α-secreting M2-macrophages to exacerbate pancreatic ductal adenocarcinoma.
Fan CS; Chen LL; Hsu TA; Chen CC; Chua KV; Li CP; Huang TS
J Hematol Oncol; 2019 Dec; 12(1):138. PubMed ID: 31847880
[TBL] [Abstract][Full Text] [Related]
9. TNF-α induces endothelial-mesenchymal transition promoting stromal development of pancreatic adenocarcinoma.
Adjuto-Saccone M; Soubeyran P; Garcia J; Audebert S; Camoin L; Rubis M; Roques J; Binétruy B; Iovanna JL; Tournaire R
Cell Death Dis; 2021 Jun; 12(7):649. PubMed ID: 34172716
[TBL] [Abstract][Full Text] [Related]
10. Silencing of Neuropilins and GIPC1 in pancreatic ductal adenocarcinoma exerts multiple cellular and molecular antitumor effects.
Borchardt H; Schulz A; Datta K; Muders MH; Aigner A
Sci Rep; 2019 Oct; 9(1):15471. PubMed ID: 31664117
[TBL] [Abstract][Full Text] [Related]
11. CCL18 promotes epithelial-mesenchymal transition, invasion and migration of pancreatic cancer cells in pancreatic ductal adenocarcinoma.
Meng F; Li W; Li C; Gao Z; Guo K; Song S
Int J Oncol; 2015 Mar; 46(3):1109-20. PubMed ID: 25502147
[TBL] [Abstract][Full Text] [Related]
12. CCR7 regulates Twist to induce the epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma.
Li K; Xu B; Xu G; Liu R
Tumour Biol; 2016 Jan; 37(1):419-24. PubMed ID: 26219899
[TBL] [Abstract][Full Text] [Related]
13. miR-15a inhibits cell proliferation and epithelial to mesenchymal transition in pancreatic ductal adenocarcinoma by down-regulating Bmi-1 expression.
Guo S; Xu X; Tang Y; Zhang C; Li J; Ouyang Y; Ju J; Bie P; Wang H
Cancer Lett; 2014 Mar; 344(1):40-46. PubMed ID: 24252251
[TBL] [Abstract][Full Text] [Related]
14. Expression and regulation of the novel vascular endothelial growth factor receptor neuropilin-1 by epidermal growth factor in human pancreatic carcinoma.
Parikh AA; Liu WB; Fan F; Stoeltzing O; Reinmuth N; Bruns CJ; Bucana CD; Evans DB; Ellis LM
Cancer; 2003 Aug; 98(4):720-9. PubMed ID: 12910515
[TBL] [Abstract][Full Text] [Related]
15. Stem cell marker nestin is critical for TGF-β1-mediated tumor progression in pancreatic cancer.
Su HT; Weng CC; Hsiao PJ; Chen LH; Kuo TL; Chen YW; Kuo KK; Cheng KH
Mol Cancer Res; 2013 Jul; 11(7):768-79. PubMed ID: 23552743
[TBL] [Abstract][Full Text] [Related]
16. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
[TBL] [Abstract][Full Text] [Related]
17. VEGF receptor-2/neuropilin 1 trans-complex formation between endothelial and tumor cells is an independent predictor of pancreatic cancer survival.
Morin E; Sjöberg E; Tjomsland V; Testini C; Lindskog C; Franklin O; Sund M; Öhlund D; Kiflemariam S; Sjöblom T; Claesson-Welsh L
J Pathol; 2018 Nov; 246(3):311-322. PubMed ID: 30027561
[TBL] [Abstract][Full Text] [Related]
18. HOXB9 mediates resistance to chemotherapy and patient outcomes through the TGFβ pathway in pancreatic cancer.
Chiba N; Ochiai S; Gunji T; Kobayashi T; Sano T; Tomita K; Kawachi S
Oncotarget; 2022; 13():747-754. PubMed ID: 35634239
[TBL] [Abstract][Full Text] [Related]
19. Epithelial mesenchymal transition correlates with CD24+CD44+ and CD133+ cells in pancreatic cancer.
Zhang Y; Wei J; Wang H; Xue X; An Y; Tang D; Yuan Z; Wang F; Wu J; Zhang J; Miao Y
Oncol Rep; 2012 May; 27(5):1599-605. PubMed ID: 22322379
[TBL] [Abstract][Full Text] [Related]
20. Human amniotic fluid mesenchymal stem cells attenuate pancreatic cancer cell proliferation and tumor growth in an orthotopic xenograft mouse model.
Chen YC; Lan YW; Huang SM; Yen CC; Chen W; Wu WJ; Staniczek T; Chong KY; Chen CM
Stem Cell Res Ther; 2022 Jun; 13(1):235. PubMed ID: 35659367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
